Ionis wins FDA approval for the first Alexander disease treatment, offering adults and children a new therapy for this rare disorder.
The Novartis MS Pill, Rhapsido (remibrutinib), has cleared a major Phase 3 hurdle in relapsing multiple sclerosis (RMS). But the headline comes with an important clinical caveat. The Novartis MS pill significantly reduced annualized...
Low-dose GLP-1 drugs can still help people lose weight, even when patients remain on the starter dose. However, the weight loss is much lower than results seen with higher doses.
Zydus Lifesciences just moved the needle in the global fight against liver disease. The company's EVIDENCES-X Phase II trial for Saroglitazar Mg met its primary endpoint, with 26.5 percent treatment difference over placebo to resolve steatohepatitis
India’s H1N1 cases continue to draw attention as more states strengthen surveillance and hospital preparedness. Jharkhand is now the latest state to step up its response after eight people tested positive for H1N1.
The Democratic Republic of Congo has started an Ebola vaccination campaign as cases and deaths continue to rise. The Ebola outbreak is driven by the rare Bundibugyo virus and has spread across six provinces.
Delhi has reported H1N1 cases at a rising pace, with 138 new infections recorded in the past 24 hours. The fresh cases have taken the city's 2026 H1N1 tally to 2,446. The latest rise has prompted the Delhi government to review hospital preparedness.
Cancer care gets a new boost in Japan as Biocon Biologics secures marketing approval for its pegfilgrastim biosimilar. The approval expands Biocon’s oncology portfolio and strengthens its presence in Japan’s biosimilar market
H1N1 cases have crossed 2,300 in Delhi, prompting hospitals to strengthen testing and preparedness. The capital has recorded 2,308 H1N1 cases so far in 2026. Total Influenza A and B cases have crossed around 3,000.
Palm Bioactives are gaining attention in NCD research. Scientists are exploring whether naturally occurring palm compounds can help address non-communicable diseases
.jpg)
, CDSCO.jpg)